Numinus Wellness (NUMI.V) and researcher KGK Science engage in Phase 1 psychedelics trial Post date April 26, 2021 Posted by Joseph Posted in anxiety, Biotech, Health Science, KGK Science, opioid treatment, psilocybin, psilocybin mushrooms, Psychedelics, Syreon Corporation Comments 0